Background The use of oral contraceptives (OCs) is associated with an increased risk of
cardiovascular events such as arterial and venous thrombosis (VTE). Cardiovascular …

Introduction The use of oral contraceptives (OCs) is linked to an increased risk of
cardiovascular diseases (CVDs) in women of reproductive age. CVD remain one of the top …

Context: The long-term cardiovascular safety of widely used oral contraceptives (OCs) is still
debated, and no meta-analysis assesses the modern use of OCs and the associated …

Objective Recent findings demonstrating an increased risk of cardiovascular disease in
hormone replacement therapy users prompted re-evaluation of the safety of oral …

Background The associations of oral contraceptive (OC) use with cardiovascular disease
(CVD) and all‐cause death remains unclear. We aimed to determine the associations of OC …

Background. Epidemiologic studies link oral contracep tive use with several cardiovascular
events, but the liter ature is difficult to summarize, and potential biases re main poorly …

Introduction In the WHO eligibility criteria, there is agreement that hypertensive women
taking Oral Contraceptive Hormonal Combined (OCHC) may be at increased risk of …

Objective: To analyze the relationship between third generation oral contraceptive (OC) use
and various cardiovascular risk factors—including markers of inflammation—in a population …

Background Combined oral contraceptives (COCs) have been associated with an increased
risk of arterial thrombosis, ie myocardial infarction or ischemic stroke. However, as these …

Oral contraceptives containing synthetic oestrogens have been used successfully as birth
control for> 40 years and are currently prescribed to> 100 million women worldwide. Several …